Navigation Links
NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
Date:2/18/2011

adila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. For more information about Novavax, please visit www.novavax.com.

Cautionary Note Regarding Forward-Looking Statements

Statements herein relating to future business performance, conditions or strategies and other business matters, including our assessment of the results of our products in clinical trials are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. We caution readers not to place significant reliance on the forward-looking statements contained in this release. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include, among other things,  the following: our ability to progress any product candidates in clinical trials; the scope, initiation, rate and progress of our clinical trials and other research and development activities; even with positive data from clinical trials, the product candidate may not prove to be safe and efficacious; decisions by regulatory agencies may delay or prevent our development programs or increase the costs of such programs; regulatory approval is needed before any we can initiate clinical trials on our vaccines; regulatory approval is needed before any vaccines can be sold in or outside the United States and, to date, no governmental authority has approved any of our vaccine candidates for sale; we have not manufactured any of our vaccine candidates at a commercial level; we utilize a unique manufacturing process and the scale-up of that process may prove difficult and/or costly; our dependence on third parties to manufacture and distribute our vaccines; risks associated with conducting business outside of the United States;
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials
2. NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial
3. NOVAVAX to Present at Lazard 7th Annual Healthcare Conference
4. NOVAVAX Reports Third Quarter 2010 Financial Results
5. Novavax to Report Third Quarter 2010 Financial Results on November 5, 2010
6. NOVAVAX to Present at BIO Investor Forum
7. NOVAVAX to Present at Stifel Nicolaus Conference
8. NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures
9. NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
10. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
11. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or ... that it has received final approval for its common shares ... Exchange (the "TSX"). The Company,s common shares will commence trading ... under the trading symbol ,EPI,.  Concurrently, ESSA,s common shares will ... About ESSA Pharma Inc. ESSA Pharma is a ...
(Date:7/28/2015)... 2015 According to a new market ... Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration ... to 2020", published by MarketsandMarkets, the European Injectable Drug Delivery ... $114.7 Billion in 2015, growing at a CAGR of 12.6% ... 230 market data T ables and ...
(Date:7/27/2015)... and PARIS , July ...  and Sanofi have entered into a new global ... treatments in the emerging field of immuno-oncology. As part ... a programmed cell death protein 1 (PD-1) inhibitor currently ... trials in 2016 with new therapeutic candidates based on ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8
(Date:7/28/2015)... ... ... Every summer, the public is reminded to leave the Fourth of July fireworks ... neighborhoods. Unfortunately, according to a recent report issued by the U.S. Consumer Product Safety ... Injuries Caused by Fireworks Doubled in Last 3 Years ," the number of fireworks-related ...
(Date:7/28/2015)... ... 28, 2015 , ... The PULs Cardiac Testâ„¢ identifies asymptomatic ... many of whom are missed by conventional evaluation , A currently unmet ... sub-clinical disease, who are at risk of experiencing a coronary event, and for ...
(Date:7/28/2015)... ... 28, 2015 , ... There has been much discussion in Washington, D.C. ... railroads, often overlooked is the over 740,000 miles of municipal sewer lines ... treatment facilities. According to the American Society of Civil Engineers , the average ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... provider announced HeartPlace will be expanding their cloud presence to support their rapidly ... groups in North Texas, has been serving the Dallas/Fort Worth area for almost ...
(Date:7/28/2015)... ... July 28, 2015 , ... Advanced Fertility Center ... inception in 2010, and Dr Dozortsev , a Reproductive Laboratory Director at ... In 2012, he was succeeded by Dr Gianpiero Palermo, who is credited with the ...
Breaking Medicine News(10 mins):Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3Health News:HeartPlace Announces Cloud Expansion with VAZATA 2Health News:HeartPlace Announces Cloud Expansion with VAZATA 3Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2
... 3 /PRNewswire-FirstCall/ - Two of DiagnoCure Inc.,(TSX: CUR) products, ... GCC for the staging of colorectal cancer, were discussed ... to molecular diagnostics., Yesterday, on June 2nd, DiagnoCure ... Assay Society Meeting, held in Coral,Springs, Florida, with a ...
... safe in both HIV-infected and HIVuninfected men , ... HIV disease, according to research published in PLoS Medicine. ... circumcision in the rural Rakai district of Uganda, Ron ... Hopkins University and colleagues found approximately a 3% rate ...
... Grant Will Fund Chicago Latino Outreach Program and National Latino ... ... The American Diabetes,Association (ADA) was recently awarded a $450,000 grant from ... National Latino,Outreach Toolkit. Diabetes is an urgent health problem in the ...
... Inc.,(NYSE: MED ) announced today that Michael S. ... a presentation at the,Canaccord Adams Diabetes & Obesity Conference ... the Hotel Nikko San Francisco., Interested parties can ... http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2301640 . The web,cast will be available for 60 ...
... precursors of autoantibody-secreting cells, have emerged as promising ... arthritis (RA). In particular, B cell depletion ... for RA patients resistant to standard disease-modifying antirheumatic ... blockers. In large trials, about half of ...
... 2 Katzen Eye Group is happy to,announce ... CRT.,Paragon CRT temporarily corrects nearsightedness (myopia) with or ... health of their patients, Katzen Eye Group is,continually ... vision care. Paragon CRT is a specially designed ...
Cached Medicine News:Health News:DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings 2Health News:DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings 3Health News:Study finds circumcision safe in both HIV-infected and HIV-uninfected men 2Health News:Study finds circumcision safe in both HIV-infected and HIV-uninfected men 3Health News:American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives 2Health News:Medifast, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference 2Health News:Study of anti-CD20 therapy effective B cell depletion 2Health News:Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 2
EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention th...
... a key participant in the area of ... decade. Previous Medtronic autotransfusion systems allowed clinicians ... well as to determine requirements for a ... (PRP) for a small amount of autologous ...
... SJM Pericardial Patch with EnCap technology ... vessel reconstruction/repair and for pericardial closure. ... offers surgeons durability and flexibility, plus ... patches. Equally important in a tissue ...
... triaxial catheter design and ergonomic handle ... proprietary radiopaque Nitinol markers on the ... stent enhance visibility. Corrugated ring design ... the nested ring pattern minimizes stent ...
Medicine Products: